Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial Results

Go back to Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial Results
(NASDAQ: QNRX) Delayed: 7.06 +0.05 (0.71%)
Previous Close $7.01    52 Week High
Open $6.85    52 Week Low
Day High $7.15    P/E N/A 
Day Low $6.70    EPS
Volume 15,625